Probi has signed a distribution agreement with Laboratório Daudt, the oldest Brazilian pharmaceutical company with market presence since 130 years. Following registration, Lab. Daudt plans to launch Probi Digestis® during 2015.
Probi AB and Lab. Daudt have agreed to launch the Swedish market-leading probiotic supplement Probi Mage® on the Brazilian market.
“Key to success in such a large market is distribution into the most important of the 65 000 pharmacies, along with professional contacts with the gastroenterology specialists. Lab. Daudt have these networks, and this is why Probi is very pleased to sign with Daudt,” says Peter Nählstedt, CEO of Probi.
Brazil has a growing probiotic market larger than USD 60 million, three times the size of the Swedish market, according to Euromonitor with several new players successfully launching new probiotic products why Brazil represents a key opportunity in the years to come.
“We are committed to gaining market share in Brazil in the years to come,” says Gustavo Daudt, vice president. Probi Digestis has a large number of positive clinical studies within gut health.”
Probi Digestis is based on Lactobacillus plantarum 299v (DSM 9843), targeting bloating, gas formation and pain, all common symptoms that are sometimes mild or temporary but often more severe and causing a low quality of life for people suffering from such symptoms.
“Probi Digestis will be launched under a specific IBS brand complementing Lab. Daudt’s presence in the category,” Gustavo Daudt continues, adding: “We are pleased to enter into a cooperation with Probi of Sweden, one of the leading probiotic science companies in the industry.”